{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:58:26Z","timestamp":1791305906594,"version":"4.3.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1016\/j.maturitas.2003.09.016","type":"journal-article","created":{"date-parts":[[2003,11,20]],"date-time":"2003-11-20T08:03:07Z","timestamp":1069315387000},"page":"31-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"S1","title":["Differential effects of progestins on hemostasis"],"prefix":"10.1016","volume":"46","author":[{"given":"Adolf E","family":"Schindler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2003.09.016_BIB1","doi-asserted-by":"crossref","unstructured":"Hulley S, Grady D, Furberg C, Herrington D, Rix B, et al. (for the HERS Research Group). Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart\/Estrogen Replacement Study (HERS) group. JAMA 1998;280:605\u2013613.","DOI":"10.1001\/jama.280.7.605"},{"key":"10.1016\/j.maturitas.2003.09.016_BIB2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/jama.288.1.49","article-title":"Cardiovascular disease outcomes during 6.8 years of hormone replacement therapy. Heart Estrogen\/Progestin Replacement Study Follow-up (HERS II)","volume":"288","author":"Grady","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2003.09.016_BIB3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/jama.288.1.58","article-title":"Noncardiovascular disease outcomes during 6.8 years of hormone therapy. Heart Estrogen\/Progestin Replacement Study Follow-up (HERS II)","volume":"288","author":"Hulley","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2003.09.016_BIB4","doi-asserted-by":"crossref","unstructured":"Writing Group for the Women\u2018s Health Initiative Investigators. Risks and Benefits of Estrogen plus Progestin in Healthy Postmenopausal Women. JAMA 2002;288:321\u2013333.","DOI":"10.1001\/jama.288.3.321"},{"key":"10.1016\/j.maturitas.2003.09.016_BIB5","first-page":"8","article-title":"Hormontherapie und Blutgerinnung","volume":"7","author":"Lankes","year":"2002","journal-title":"Menopause Prax."},{"key":"10.1016\/j.maturitas.2003.09.016_BIB6","first-page":"17","article-title":"Gestagene und H\u00e4mostase","volume":"119","author":"Schindler","year":"1997","journal-title":"Zbl. Gyn\u00e4k."},{"key":"10.1016\/j.maturitas.2003.09.016_BIB7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1055\/s-0038-1655915","article-title":"The effect of progestin on the hemostatic mechanism","volume":"77","author":"Blomb\u00e4ck","year":"1997","journal-title":"Thromb. Hemost."},{"key":"10.1016\/j.maturitas.2003.09.016_BIB8","first-page":"32","article-title":"Der Einfluss zyklisch verabreichter Gestagene auf die plasmatischen Gerinnungsfaktoren","volume":"120","author":"Winkler","year":"1998","journal-title":"Zbl. Gyn\u00e4k."},{"key":"10.1016\/j.maturitas.2003.09.016_BIB9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1053\/ob.1998.v179.a92633","article-title":"Effects on hemostatic variables of desogestrel and gestodene-containing oral contraceptives in comparison with levonorgestrel-containing oral contraceptives: A review","volume":"179","author":"Winkler","year":"1998","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.maturitas.2003.09.016_BIB10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-5122(96)00994-2","article-title":"Effects of progestins on hemostasis","volume":"24","author":"Kuhl","year":"1996","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2003.09.016_BIB11","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0010-7824(98)00045-6","article-title":"A randomized controlled double-blind study of the effects on hemostasis of two progesterone-only pills containing 75\u03bc desogestrel or 30\u03bc levonorgestrel","volume":"57","author":"Winkler","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.maturitas.2003.09.016_BIB12","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/humupd\/5.3.200","article-title":"Effects of progestins on cardiovascular diseases: the haemostatic system","volume":"5","author":"Winkler","year":"1999","journal-title":"Human Reprod. Update"},{"key":"10.1016\/j.maturitas.2003.09.016_BIB13","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0010-7824(75)80047-3","article-title":"Study of blood coagulation in women treated with megestrol acetate","volume":"12","author":"Lira","year":"1973","journal-title":"Contraception"},{"key":"10.1016\/j.maturitas.2003.09.016_BIB14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0010-7824(92)90133-E","article-title":"Effect of Norplant-2 rods on hemostatic functions","volume":"46","author":"Singh","year":"1992","journal-title":"Contraception"},{"key":"10.1016\/j.maturitas.2003.09.016_BIB15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1447-0756.1999.tb01144.x","article-title":"A prospective study on the effects of reformulated 2-rod Norplant in hemostasis after five years of age","volume":"25","author":"Koh","year":"1999","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.maturitas.2003.09.016_BIB16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1447-0756.2000.tb01195.x","article-title":"Contraception in diabetic women: comparative metabolic study of norplant, depot medroxyprogesterone acetate","volume":"26","author":"Diab","year":"2000","journal-title":"J. Obstet. Gynecol. Res."},{"key":"10.1016\/j.maturitas.2003.09.016_BIB17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0010-7824(98)00070-5","article-title":"Effects on the hemostatic system and liver function in relation to implanon\u00ae and norplant\u00ae","volume":"58","author":"Egberg","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.maturitas.2003.09.016_BIB18","unstructured":"Oberhoff C, Winkler UH, Schindler AE, Hemostasis in women taking megestrol acetate for advanced gynecological cancer. J Cancer Res Clin Oncol 1994;(Suppl. 120):R42."},{"key":"10.1016\/j.maturitas.2003.09.016_BIB19","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/gye.15.5.341.348","article-title":"Hemostatic effects of high dose megestrol acetate therapy in patients with advanced gynaecological cancer","volume":"15","author":"Oberhoff","year":"2001","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.maturitas.2003.09.016_BIB20","first-page":"93","article-title":"Effect of high-dose progestogen on hemostatic properties of blood in patients with endometrial cancer","volume":"24","author":"Kaibara","year":"2001","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"10.1016\/j.maturitas.2003.09.016_BIB21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0277-5379(90)90231-H","article-title":"A randomized comparison of megestrol acetate (MA) and medroxyprogesterone acetate (MPA) in patients with advanced cancer","volume":"26","author":"Willemse","year":"1990","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.maturitas.2003.09.016_BIB22","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1349-7006.1991.tb01865.x","article-title":"Changes in hemostatic parameters during treatment with medroxyprogesterone acetate for breast cancer","volume":"82","author":"Yamamoto","year":"1991","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.maturitas.2003.09.016_BIB23","first-page":"99","article-title":"Hemostasis and high dose gestagen treatment in gynaecological oncology","volume":"7","author":"Schindler","year":"1993","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.maturitas.2003.09.016_BIB24","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1056\/NEJM200105173442007","article-title":"Oral contraceptives and the risk of venous thrombosis","volume":"344","author":"Vandenbrouke","year":"2001","journal-title":"N. Eng. J. Med."},{"key":"10.1016\/j.maturitas.2003.09.016_BIB25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0010-7824(01)00307-9","article-title":"Oral contraceptives and venous thromboembolism: a five-year national case-control study","volume":"65","author":"Lidegaard","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.maturitas.2003.09.016_BIB26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0010-7824(01)00306-7","article-title":"Contraceptives and cerebral thrombosis: a five-year national case-control study","volume":"65","author":"Lidegaard","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.maturitas.2003.09.016_BIB27","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1055\/s-0037-1612973","article-title":"Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of factor V Leiden mutation","volume":"87","author":"Kemmmeren","year":"2002","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.maturitas.2003.09.016_BIB28","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0010-7824(01)00274-8","article-title":"Third-generation progestogen type influences hemostatic changes caused by oral contraceptives in Brazilian women","volume":"64","author":"Ferreira","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.maturitas.2003.09.016_BIB29","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0010-7824(01)00312-2","article-title":"Long-term effects of combined oral contraceptives on markers of endothelial function and lipids in healthy premenopausal women","volume":"65","author":"Merki-Feld","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.maturitas.2003.09.016_BIB30","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/gye.16.4.335.346","article-title":"The effects of postmenopausal hormone replacement therapy on hemostatic variables: a meta-analysis of 46 studies","volume":"16","author":"Acs","year":"2002","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.maturitas.2003.09.016_BIB31","first-page":"421","article-title":"Progestadifs, Progesterone Coagulation et Tonus Vasculaire","volume":"30","author":"Schved","year":"2002","journal-title":"Gynecol. Obstet. Fertil."},{"key":"10.1016\/j.maturitas.2003.09.016_BIB32","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0015-0282(98)00513-5","article-title":"Long-term effects of combined hormone replacement therapy on markers of endothelial function and inflammatory activity in healthy postmenopausal women","volume":"71","author":"Van Baal","year":"1999","journal-title":"Fert. Steril."},{"key":"10.1016\/j.maturitas.2003.09.016_BIB33","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1161\/01.CIR.103.15.1961","article-title":"Vascular Effects of Synthetic or Natural Progestagen combined with Conjugated Equine Estrogen in Healthy Postmenopausal Women","volume":"103","author":"Koh","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.maturitas.2003.09.016_BIB34","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0378-5122(01)00242-0","article-title":"Effect of estradiol valerate alone or in association with cyproterone acetate upon vascular function of postmenopausal women at increased risk for cardiovascular disease","volume":"40","author":"Vitale","year":"2001","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2003.09.016_BIB35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0378-5122(02)00184-6","article-title":"Dydrogesterone does not reverse the effects of estradiol on endothelium-dependant vasodilation in postmenopausal women: a randomised clinical trial","volume":"43","author":"Gambacciani","year":"2002","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2003.09.016_BIB36","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00042192-200101000-00003","article-title":"Effect of medroxyprogesterone acetate and norethisterone on serum-stimulated and estradiol-inhibited proliferation of human coronary artery smooth muscle cells","volume":"8","author":"Seeger","year":"2001","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2003.09.016_BIB37","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1161\/hc4801.099737","article-title":"Sex steroids used in hormonal treatment increase vascular procoagulant activity by including thrombin receptor (PAR-1) expression. Role of the glucocorticoid receptor","volume":"104","author":"Herkert","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.maturitas.2003.09.016_BIB38","unstructured":"Winkler UH, B\u00fchler K, Oberhoff C, Koslowski S, H\u00f6lscher T, Goitowski S, et al. The dynamic balance of hemostasis: a key for understanding thromboembolism in oral contraceptive users, Curr Res Gynecol Obstet 1991;389\u201394."},{"key":"10.1016\/j.maturitas.2003.09.016_BIB39","doi-asserted-by":"crossref","unstructured":"Million Women Study Collaborators: Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362:419\u201327.","DOI":"10.1016\/S0140-6736(03)14065-2"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512203003323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512203003323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:37:19Z","timestamp":1759912639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512203003323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":39,"alternative-id":["S0378512203003323"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2003.09.016","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential effects of progestins on hemostasis","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2003.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}